Nasal Flu Vaccine stimulates the immune system and helps to prevent influenza in people. According to World Health Organization (WHO) reports, many individuals are admitted to hospitals due to influenza (commonly known as flu), and some of them die from it each year. Due to the non-invasive nature, simplified administration, and high immunization potential, nasal vaccines are rapidly becoming more viable alternatives to other routes of vaccine administration. The government initiatives to provide flu vaccines to children and the growing awareness about flu vaccines in the developing economies and underdeveloped economies are speculated to offer lucrative opportunities in the market.
MARKET SCOPE
The "Global Nasal Flu Vaccine Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the nasal flu vaccine market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading nasal flu vaccine market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
-Based on type, the global nasal flu vaccine market is segmented into trivalent flu vaccine, quadrivalent flu vaccine.
-On the basis of end use, the market is segmented into hospitals, clinics, others.
MARKET DYNAMICS
Drivers-
- Rise in the incidences of several respiratory infections.
- Ongoing corona virus epidemic.
- Amplifies patient compliance and better absorption.
- Some of the side effects of nasal flu vaccine are the major restraining factors for this market.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The nasal flu vaccine market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the nasal flu vaccine market in these regions.
IMPACT OF COVID-19 ON NASAL FLU VACCINE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Despite of all of these hurdles, Nasal Flu Vaccine Market is in demand due to COVID-19.
MARKET PLAYERS
The report covers key developments in the nasal flu vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from nasal flu vaccine market are anticipated to lucrative growth opportunities in the future with the rising demand for nasal flu vaccine in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the nasal flu vaccine market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
-GlaxoSmithKline Plc
-Sanofi
-Abbott
-AstraZeneca
-Serum Institute of India Pvt. Ltd.
-CSL Ltd
-Bharat Biotech
-Antares Pharma
-INJEX Pharma GmbH
-BioDiem